Annals of Oncology 15:355-356, 2004
© 2004 European Society for Medical Oncology
Lesson learned from high-dose chemotherapy for high-risk breast cancer (What you see is what you mean)
1 Department of Medicine, 2 Department of Epidemiology and Biostatistics, and 3 Division of Hemato-oncology, Department of Medicine, European Institute of Oncology, Milan, Italy; 4 Department of Biostatistical Science, Dana-Farber Cancer Institute, Boston, USA; 5 The Cancer Council Australia, Sydney, NSW, Australia; 6 Oncology Institute of Southern Switzerland, Lugano, Switzerland, and Department of Medicine, European Institute of Oncology, Milan, Italy
*E-mail: marco.colleoni@ieo.it
| The first 10% of the full text of this article appears below. |
Recognition of the importance of receptor expression is crucial for understanding treatment effects in the adjuvant treatment of breast cancer. The Netherlands Working Party on Autologous Transplantation in Solid Tumors recently presented the results of a randomized study comparing conventional dose chemotherapy with conventional dose chemotherapy followed by high-dose chemotherapy [1
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Colleoni, G. Viale, D. Zahrieh, L. Bottiglieri, R. D. Gelber, P. Veronesi, A. Balduzzi, R. Torrisi, A. Luini, M. Intra, et al. Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy Ann. Onc., March 1, 2008; 19(3): 465 - 472. [Abstract] [Full Text] [PDF] |
||||
